A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Atopic Dermatitis
Related studies linked through entity extraction aliases.
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
- Status
- COMPLETED
- Phase
- N/A
Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological Indicators
- Status
- COMPLETED
- Phase
- NA
An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Seal, Stopping Eczema and Allergy Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Eczema Reminder and Accountability Program
- Status
- COMPLETED
- Phase
- NA
A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer
- Status
- COMPLETED
- Phase
- NA
Investigation of Flare and Remission in Subjects With Atopic Dermatitis
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE1